| Product NDC: | 0591-0810 |
| Proprietary Name: | Silver Sulfadiazene |
| Non Proprietary Name: | Silver Sulfadiazine |
| Active Ingredient(s): | 10 g/1000g & nbsp; Silver Sulfadiazine |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0591-0810 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018578 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19820225 |
| Package NDC: | 0591-0810-85 |
| Package Description: | 85 g in 1 TUBE (0591-0810-85) |
| NDC Code | 0591-0810-85 |
| Proprietary Name | Silver Sulfadiazene |
| Package Description | 85 g in 1 TUBE (0591-0810-85) |
| Product NDC | 0591-0810 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Silver Sulfadiazine |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 19820225 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | SILVER SULFADIAZINE |
| Strength Number | 10 |
| Strength Unit | g/1000g |
| Pharmaceutical Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient] |